Atlas Trials

Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

Clinical trial NCT00413335 · COMPLETED

Trial details

NCT number
NCT00413335
Sponsor
Yale University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
ObesityImpaired Glucose ToleranceType 2 Diabetes Mellitus
Start date
2005-11-01
Primary completion
2008-09-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.